MINNEAPOLIS, MN – May 14, 2025 – Spinnaker Life Sciences Strategy Consulting LLC, a leading life sciences strategy consulting firm, is pleased to announce that Managing Partner Jeremy Cohen authored a featured article in the April 2025 issue of MedTech Strategist. Titled “The Next Frontier: Transforming Medical Device Commercialization,” the piece explores the significant shifts occurring in the healthcare customer landscape and provides insights for medical device companies to adapt and thrive.
Cohen outlines the market forces reshaping the industry – including hospital consolidation, private equity investment, the growth of ambulatory surgery centers (ASCs), and the acceleration of digital engagement. He argues that the traditional medical device sales model, heavily reliant on in-person presence, must evolve to remain effective in this new environment.
The article outlines key strategies for medical device companies to navigate this changing environment, including aligning commercial models with customer priorities, reducing inefficiencies, and leveraging technology for smarter decision-making. Cohen also discusses the benefits of hybrid sales models, the importance of customer experience, driving operational efficiency through digital tools and inside sales, and unlocking growth in emerging segments like ASCs and Integrated Delivery Networks (IDNs).
“The medical device industry stands at a pivotal moment,” says Cohen. “Companies that proactively embrace these changes and build resilient, scalable, and differentiated commercial models will be best positioned for long-term success.”
Jeremy Cohen is a co-founder and partner at Spinnaker Life Sciences Strategy Consulting. His deep expertise in the medical device sector provides valuable insights for industry leaders navigating today’s complex market.
The full article is available in the April 2025 issue of MedTech Strategist and can be found on Spinnaker’s Insights page.
About Spinnaker Life Sciences Strategy Consulting LLC
Spinnaker Life Sciences is a strategy consulting firm dedicated to helping life sciences companies achieve their growth objectives. With expertise spanning pharmaceuticals, biotechnology, and medical devices, Spinnaker provides strategic guidance and actionable insights to address critical business challenges. The firm has offices in Boston and Minneapolis.
For general and media inquiries:
Erin Rooney
Spinnaker Life Sciences Strategy Consulting
617-485-1525
